Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 1, 2022
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
[ Tue, Feb 01st 2022
] - WOPRAI
Matthew Sharpe Maintained (CACI) at Hold with Decreased Target to $286 on, Feb 1st, 2022
Matthew Sharpe of Morgan Stanley, Maintained "CACI International Inc" (CACI) at Hold with Decreased Target from $299 to $286 on, Feb 1st, 2022.
Matthew has made no other calls on CACI in the last 4 months.
There are 3 other peers that have a rating on CACI. Out of the 3 peers that are also analyzing CACI, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Brian Gesuale of "Raymond James" Upgraded from Hold to Buy and Held Target at $300 on, Monday, January 31st, 2022
- David Strauss of "Barclays" Maintained at Buy with Increased Target to $320 on, Monday, November 8th, 2021
- Matthew Akers of "Wells Fargo" Maintained at Buy with Increased Target to $330 on, Monday, November 1st, 2021
